Investing.com -- 专注于神经科学的生物制药公司Xenon制药公司(NASDAQ:XENE)股价飙升6.4%,此前该公司报告的第二季度业绩大幅超过分析师预期。该公司公布每股收益为1.07美元,比分析师预估的-0.99美元高出2.06美元。 盘坚反应反映了投资者对这一显著业绩超预期的热情,尽管该公司继续在其后期临床项目上进行大量投资。Xenon报告截至2025年6月30日的季度净亏损为...
Source LinkInvesting.com -- 专注于神经科学的生物制药公司Xenon制药公司(NASDAQ:XENE)股价飙升6.4%,此前该公司报告的第二季度业绩大幅超过分析师预期。该公司公布每股收益为1.07美元,比分析师预估的-0.99美元高出2.06美元。 盘坚反应反映了投资者对这一显著业绩超预期的热情,尽管该公司继续在其后期临床项目上进行大量投资。Xenon报告截至2025年6月30日的季度净亏损为...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.